Dosing Calculator

Contact a Representative

Efficacy Endpoints

Study endpoints on the 2 clinical trials on patients who have hemophilia A with FVIII inhibitors

Treating Breakthrough Bleeds

Guidelines for addressing breakthrough bleeds

HEMLIBRA Laboratory Monitoring Information

Considerations for using lab tests to monitor HEMLIBRA patients

Support for Your Patients

Financial support, useful tools, and helpful resources for your patients